project id: TCGA-MESO; case submitter id: TCGA-UD-AAC4; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.85; rna integrity number: 8.8; age at index: 65; days to birth: -23949; days to death: 719; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1939; year of death: 2005; age at diagnosis: 23949; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage III; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9050/3; primary diagnosis: Mesothelioma, malignant; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2004; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 490.0; portion submitter id: TCGA-UD-AAC4-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 17.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 83.0; percent tumor nuclei: 70.0;